{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiewhnbjm4573wuveg2pktq3ydjjqpsykbzs5z4xoe6dkcyfcp6mhm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3modeifap6wg2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiajatdw7uklj7742zt52dcfjlh4x3cz2fljiwr2ksel267ylzxkzy"
    },
    "mimeType": "image/jpeg",
    "size": 189152
  },
  "path": "/news/2026-06-biological-content-blood-derived-treatment.html",
  "publishedAt": "2026-06-15T08:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Injections of platelet-rich plasma made from a patient's own blood are increasingly used to treat knee osteoarthritis, but their use is not widely accepted, and the treatment does not work for everyone. Investigators from Cedars-Sinai Health Sciences University have taken the first steps toward predicting which patients will benefit.",
  "title": "Biological content of blood-derived treatment could affect common arthritis"
}